Over-expression of the facilitative GLUT1 protein has been observed in a large array of human cancer types suggesting that it likely plays a role in tumor initiation, progression and modulation of tumor immune microenvironment (TME) [38,39,40]. The gene discussed is SLC2A1; the disease is neoplasm.